Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-09

Clinical Trial Update: Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients undergoing islet transplantat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-09